Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
180 participants
OBSERVATIONAL
2025-09-26
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thus, the potential consequences of a stay in intensive care may take several forms: 1) quality of life on leaving intensive care, 2) the occurrence or persistence of physical, psychological/psychiatric and/or cognitive symptoms grouped together under the term Post Intensive Care Syndrome (PICS) and PICS-F when these manifestations concern the patient's relatives (F for Family) and 3) socio-economic status (SE) prior to admission with risks of a drop in income, social isolation and withdrawal, and the development of feelings of uselessness or of being a burden on family and friends. This last point is particularly important because social inequalities in health (SIH), which are a true reflection of the link between health and social determinants (income and social status, employment and working conditions, education/literacy, healthy environment and support, behaviours, access to health services), represent a higher risk of being admitted to intensive care with greater severity and a more serious short-term prognosis in intensive care and post-resuscitation. The concept of PICS and PICS-F makes it possible to highlight the importance of each of these physical, psychological and cognitive dimensions in the main spheres of the daily life of patients and their relatives after resuscitation: family and social life, professional and private activity, economic resources. In addition to the manifestations of PICS, we must therefore add the impact that SE status can have on the pre- and post-resuscitation phases of a stay in intensive care. In this way, SE status and SIH reveal the weaknesses of a healthcare system and the social gradient associated with precariousness. As was shown during the Covid-19 pandemic, SIHs are probably factors that can add up and/or potentiate each other and have a significant influence on the outcome of patients leaving the intensive care unit and beyond.
" Post Intensive Care Syndrome " (PICS) The frequency and intensity of disabling symptoms in the ICU and in the aftermath of an ICU stay vary widely. These may be physical (e.g. extreme muscle weakness in around 40% of patients), psychological (anxiety, depression, post-traumatic stress disorder in 20 to 35% of patients) or cognitive (memory loss, loss of verbal fluency, problems with attention, executive functions and visio-spatial perception in 20 to 40% of patients). Cognitive impairment occurs most often in the aftermath of an acute confusional state ("delirium"), which develops in intensive care and whose causes are multifactorial, but linked in particular to the underlying disease and the treatments administered in intensive care. The aim, after the stay in intensive care and on return home, is to be able to detect one or other of the components of the PICS using easy-to-use tools as part of personalised monitoring by telephone, during a consultation in a GP's surgery or hospital, or during a medical visit to the patient's home, in order to adapt physical, cognitive, psychological and speech rehabilitation and the return to an acceptable quality of life for patients and their families. Patient follow-up, particularly in the context of the PICS, could be monitored by a resuscitation doctor as part of a post-resuscitation consultation, as proposed by the Haute Autorité de Santé in France in June 2023.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of the Post-intensive Care Syndrome
NCT05690438
Long-term Follow up in Survivors of Critical Illness
NCT04608994
Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region
NCT07290712
Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19
NCT04619368
Impact of Socio-economic Vulnerability on Initial Severity and Prognosis in Patients Admitted to an ICU.
NCT01907581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patient
90 intensive care patients
EPICES score
EPICES score used to group participants as "precarious" and "non precarious".
PICS evaluation
* Assessment of physical symptoms using the Timed up and go test (TUG)
* Assessment of depressive symptoms using the PHQ-8 and anxiety symptoms using the GAD-7 and screening for post-traumatic stress disorder using the IES-R
* Assessment of cognitive disorders using the MoCA
patient's relatives
a maximum of 90 of the patient's relatives
EPICES score
EPICES score used to group participants as "precarious" and "non precarious".
PICS-F evaluation
* Assessment of depressive symptoms using the PHQ-8 and anxiety symptoms using the GAD-7
* Screening for post-traumatic stress disorder using the IES-R
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EPICES score
EPICES score used to group participants as "precarious" and "non precarious".
PICS evaluation
* Assessment of physical symptoms using the Timed up and go test (TUG)
* Assessment of depressive symptoms using the PHQ-8 and anxiety symptoms using the GAD-7 and screening for post-traumatic stress disorder using the IES-R
* Assessment of cognitive disorders using the MoCA
PICS-F evaluation
* Assessment of depressive symptoms using the PHQ-8 and anxiety symptoms using the GAD-7
* Screening for post-traumatic stress disorder using the IES-R
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients hospitalised in intensive care for septic shock or acute respiratory distress syndrome or with a duration of mechanical ventilation and/or treatment with catecholamines ≥ 3 days (population targeted by the HAS 2023 recommendations for the risk of developing a PICS).
* Patients who have given their oral consent after having been informed about the conduct of this study.
Patient's relatives :
* Person identified by the patient as the reference person or the person to be informed
* Person who has given oral consent after having been informed about the conduct of this study
* Person able to complete a questionnaire
* Limited to 1 relative per patient
Exclusion Criteria
* Patient not affiliated to or not benefiting from a social security scheme
* Patients who are minors
* Person subject to a legal protection measure (curatorship, guardianship)
* Person subject to a legal protection measure
* Patient unable to understand the French language and to consent to the research protocol
* Major incapable or unable to express consent
* A bedridden or demented patient
Patient's relatives :
* Minor
* Relative unable to be interviewed due to state of health
* Relative under guardianship, curatorship or safeguard of justice
* Relative unable to understand the French language and to consent to the research protocol
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LABRUYERE AOI 2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.